Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis

Stanley Golden, Stephanie J. Teets, Erik B. Lehman, Elizabeth A. Mauger, Vernon Chinchilli, Joshua M. Berlin, Sujani Kakumanu, Timothy Lucus, Timothy Craig

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Background: Recent data suggested that daytime somnolence in patients with allergic rhinitis was secondary to disrupted sleep caused by nasal congestion. Medications, which decreased congestion, would be expected to improve sleep and daytime somnolence. Previously, we demonstrated that nasal steroids improved all three symptoms. The effect of topical nasal antihistamines on these symptoms has yet to be studied. Objective: The objective of this 8-week, double-blind, placebo-controlled study was to determine whether topical nasal azelastine was effective at decreasing congestion, daytime somnolence, and improving sleep. Methods: We recruited 24 subjects with perennial allergic rhinitis and randomized them in a double-blinded, crossover fashion, to receive placebo or azelastine two sprays BID, using Balaam's design. Questionnaires, daily diary, and Epworth Sleepiness Scale were used as tools. The last 2 weeks of each 4-week treatment period were summarized, scored, and compared by PROC MIXED in SAS. Results: The analysis of the Rhinitis Severity Score showed significant improvement only of rhinorrhea in the azelastine group (P = .03). The symptom severity of nasal congestion and daytime somnolence was not significantly different between placebo and azelastine. Subjects considered azelastine effective at improving their sleep (P = .04), but daytime somnolence (P = .06) and congestion (P = .09) were not statistically improved. Conclusion: Azelastine is effective in reducing rhinorrhea and improving sleep quality. We were unable to demonstrate that azelastine can significantly reduce the severity of congestion or daytime somnolence.

Original languageEnglish (US)
Article number62434
Pages (from-to)53-57
Number of pages5
JournalAnnals of Allergy, Asthma and Immunology
Volume85
Issue number1
DOIs
StatePublished - Jan 1 2000

Fingerprint

azelastine
Rhinitis, Allergic, Perennial
Rhinitis
Nose
Sleep
Placebos
Histamine Antagonists
Steroids

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Pulmonary and Respiratory Medicine

Cite this

Golden, Stanley ; Teets, Stephanie J. ; Lehman, Erik B. ; Mauger, Elizabeth A. ; Chinchilli, Vernon ; Berlin, Joshua M. ; Kakumanu, Sujani ; Lucus, Timothy ; Craig, Timothy. / Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. In: Annals of Allergy, Asthma and Immunology. 2000 ; Vol. 85, No. 1. pp. 53-57.
@article{7357547b7bc440c9bc62b42bb17a543e,
title = "Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis",
abstract = "Background: Recent data suggested that daytime somnolence in patients with allergic rhinitis was secondary to disrupted sleep caused by nasal congestion. Medications, which decreased congestion, would be expected to improve sleep and daytime somnolence. Previously, we demonstrated that nasal steroids improved all three symptoms. The effect of topical nasal antihistamines on these symptoms has yet to be studied. Objective: The objective of this 8-week, double-blind, placebo-controlled study was to determine whether topical nasal azelastine was effective at decreasing congestion, daytime somnolence, and improving sleep. Methods: We recruited 24 subjects with perennial allergic rhinitis and randomized them in a double-blinded, crossover fashion, to receive placebo or azelastine two sprays BID, using Balaam's design. Questionnaires, daily diary, and Epworth Sleepiness Scale were used as tools. The last 2 weeks of each 4-week treatment period were summarized, scored, and compared by PROC MIXED in SAS. Results: The analysis of the Rhinitis Severity Score showed significant improvement only of rhinorrhea in the azelastine group (P = .03). The symptom severity of nasal congestion and daytime somnolence was not significantly different between placebo and azelastine. Subjects considered azelastine effective at improving their sleep (P = .04), but daytime somnolence (P = .06) and congestion (P = .09) were not statistically improved. Conclusion: Azelastine is effective in reducing rhinorrhea and improving sleep quality. We were unable to demonstrate that azelastine can significantly reduce the severity of congestion or daytime somnolence.",
author = "Stanley Golden and Teets, {Stephanie J.} and Lehman, {Erik B.} and Mauger, {Elizabeth A.} and Vernon Chinchilli and Berlin, {Joshua M.} and Sujani Kakumanu and Timothy Lucus and Timothy Craig",
year = "2000",
month = "1",
day = "1",
doi = "10.1016/S1081-1206(10)62434-9",
language = "English (US)",
volume = "85",
pages = "53--57",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "1",

}

Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. / Golden, Stanley; Teets, Stephanie J.; Lehman, Erik B.; Mauger, Elizabeth A.; Chinchilli, Vernon; Berlin, Joshua M.; Kakumanu, Sujani; Lucus, Timothy; Craig, Timothy.

In: Annals of Allergy, Asthma and Immunology, Vol. 85, No. 1, 62434, 01.01.2000, p. 53-57.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis

AU - Golden, Stanley

AU - Teets, Stephanie J.

AU - Lehman, Erik B.

AU - Mauger, Elizabeth A.

AU - Chinchilli, Vernon

AU - Berlin, Joshua M.

AU - Kakumanu, Sujani

AU - Lucus, Timothy

AU - Craig, Timothy

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Background: Recent data suggested that daytime somnolence in patients with allergic rhinitis was secondary to disrupted sleep caused by nasal congestion. Medications, which decreased congestion, would be expected to improve sleep and daytime somnolence. Previously, we demonstrated that nasal steroids improved all three symptoms. The effect of topical nasal antihistamines on these symptoms has yet to be studied. Objective: The objective of this 8-week, double-blind, placebo-controlled study was to determine whether topical nasal azelastine was effective at decreasing congestion, daytime somnolence, and improving sleep. Methods: We recruited 24 subjects with perennial allergic rhinitis and randomized them in a double-blinded, crossover fashion, to receive placebo or azelastine two sprays BID, using Balaam's design. Questionnaires, daily diary, and Epworth Sleepiness Scale were used as tools. The last 2 weeks of each 4-week treatment period were summarized, scored, and compared by PROC MIXED in SAS. Results: The analysis of the Rhinitis Severity Score showed significant improvement only of rhinorrhea in the azelastine group (P = .03). The symptom severity of nasal congestion and daytime somnolence was not significantly different between placebo and azelastine. Subjects considered azelastine effective at improving their sleep (P = .04), but daytime somnolence (P = .06) and congestion (P = .09) were not statistically improved. Conclusion: Azelastine is effective in reducing rhinorrhea and improving sleep quality. We were unable to demonstrate that azelastine can significantly reduce the severity of congestion or daytime somnolence.

AB - Background: Recent data suggested that daytime somnolence in patients with allergic rhinitis was secondary to disrupted sleep caused by nasal congestion. Medications, which decreased congestion, would be expected to improve sleep and daytime somnolence. Previously, we demonstrated that nasal steroids improved all three symptoms. The effect of topical nasal antihistamines on these symptoms has yet to be studied. Objective: The objective of this 8-week, double-blind, placebo-controlled study was to determine whether topical nasal azelastine was effective at decreasing congestion, daytime somnolence, and improving sleep. Methods: We recruited 24 subjects with perennial allergic rhinitis and randomized them in a double-blinded, crossover fashion, to receive placebo or azelastine two sprays BID, using Balaam's design. Questionnaires, daily diary, and Epworth Sleepiness Scale were used as tools. The last 2 weeks of each 4-week treatment period were summarized, scored, and compared by PROC MIXED in SAS. Results: The analysis of the Rhinitis Severity Score showed significant improvement only of rhinorrhea in the azelastine group (P = .03). The symptom severity of nasal congestion and daytime somnolence was not significantly different between placebo and azelastine. Subjects considered azelastine effective at improving their sleep (P = .04), but daytime somnolence (P = .06) and congestion (P = .09) were not statistically improved. Conclusion: Azelastine is effective in reducing rhinorrhea and improving sleep quality. We were unable to demonstrate that azelastine can significantly reduce the severity of congestion or daytime somnolence.

UR - http://www.scopus.com/inward/record.url?scp=0033856325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033856325&partnerID=8YFLogxK

U2 - 10.1016/S1081-1206(10)62434-9

DO - 10.1016/S1081-1206(10)62434-9

M3 - Article

C2 - 10923605

AN - SCOPUS:0033856325

VL - 85

SP - 53

EP - 57

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 1

M1 - 62434

ER -